Gene delivery strategies for cartilage tissue engineering
- 7 July 2006
- journal article
- review article
- Published by Elsevier BV in Advanced Drug Delivery Reviews
- Vol. 58 (4), 592-603
- https://doi.org/10.1016/j.addr.2006.03.005
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I)Gene Therapy, 2005
- The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilageArthritis & Rheumatism, 2004
- Articular cartilage repair by gene therapy using growth factor–producing mesenchymal cellsArthritis & Rheumatism, 2003
- Gene mediated insulin‐like growth factor‐I delivery to the synoviumJournal of Orthopaedic Research, 2001
- Increased matrix synthesis following adenoviral transfer of a transforming growth factor β1 gene into articular chondrocytesJournal of Orthopaedic Research, 2000
- IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosionJCI Insight, 2000
- Tissue Engineering: Orthopedic ApplicationsAnnual Review of Biomedical Engineering, 1999
- Resurfacing of articular cartilage explants with genetically-modified human chondrocytesin vitroOsteoarthritis and Cartilage, 1998
- Prevention of murine collagen‐induced arthritis in the knee and ipsilateral paw by local expression of human interleukin‐1 receptor antagonist protein in the kneeArthritis & Rheumatism, 1997
- Chondrocytes inhibit endothelial sprout formation in vitro: Evidence for involvement of a transforming growth factor‐betaJournal of Cellular Physiology, 1991